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Periodate-oxidized  adenosine  triphosphate (0- ATP), 
a ribose ring-opened dialdehyde derivative of ATP, 
reacts specifically with human deoxyhemoglobin to 
give a single major covalently  modified product after 
reduction with sodium  borohydride.  This  product,  des- 
ignated  di-ATP Hb, was isolated using ion-exchange 
chromatography  and  shown to have  incorporated two 
molecules  of 0-ATP/tetrarqr. Peptide  mapping  and x- 
ray  crystallography  at 2.8-A resolution  indicate  that a
covalent  adduct is formed  between  the  ligand  and res- 
idues Lys-82 EF6  of  each /3 chain  in  the  organic  phos- 
phate-binding site of  the  molecule.  di-ATP Hb exhibits 
a significantly decreased oxygen affinity (P60 = 20.8 
mm Hg uersus 5.8 mm Hg control; 50 mM 2-[bis(2- 
hydroxyethyl)amino]-2-(hydroxymethyl)-propane- 
1,3-diol, pH 7.4, 0.1 M C, 20 "C). The  subunit  cooper- 
ativity of di-ATP Hb is also reduced (nmax = 1.9 versus 
2.7 control). 
Adenosine triphosphate (ATP) exhibits  a high affinity for 
the organic phosphate-binding  site of human hemoglobin and 
affects oxygen affinity in  a  manner similar to 2,3-diphospho- 
glycerate (1). Periodate-oxidized ATP (0-ATP)' is a ribose 
ring-opened dialdehyde ATP analog (Fig. 1) which has been 
shown to  act  as  an affinity label for several enzymes which 
use ATP as  a  substrate (2,3). Because o-ATP is bifunctional, 
it  has  the capacity for introducing intermolecular cross-link- 
ages through Schiff base formation with free amino groups. 
The organic phosphate-binding site of human hemoglobin is 
situated at  the interface of the two p chains in the central 
cavity of the molecule and contains four primary amino 
groups, Lys-82 EF6 and Val 1 NA1  from p1 and p2. Because 
of its unique chemistry, o-ATP has been used to attempt 
structural  and functional modification of hemoglobin in order 
to produce a cross-linked, low  oxygen affinity derivative which 
might be suitable for use as a cell-free blood substitute (4-6). 
Such structural  and functional modifications would address 
two of the major problems associated with infusion of native 
Hb solution as  an acellular blood substitute, i e .  rapid renal 
clearance of dissociated cup dimers and high oxygen affinity 
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[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)-propane-1,3-diol; 
HPLC, high pressure liquid chromatography. 
outside the milieu of the erythrocyte with its allosteric effec- 
tors. Other bifunctional reagents with high affinity for the 
organic phosphate-binding  site have been shown to produce 
interdimerically (ap-pa) cross-linked derivatives with signif- 
icantly decreased oxygen affinity; for example, 2-nor-2-for- 
mylpyridoxyl-5'-phosphate (7), and 4,4'-diisothiocyanostii- 
bene-2,2'-disulfonate (DIDS) (8). However, it has been shown 
that cross-linkedproducts derived from the reaction of human 
deoxyhemoglobin with o-ATP  exhibit increased oxygen affin- 
ity, presumably due to differing structural  constraints  intro- 
duced by intersubunit cross-linking with this affinity ligand 
(6). Here we report on the  structural  and functional charac- 
terization of a non-cross-linked product of the reaction of 
human deoxyhemoglobin with o-ATP which has undergone a 
monofunctional substitution leading to lowered  oxygen affin- 
ity  and  subunit cooperativity. 
EXPERIMENTAL PROCEDURES 
o-ATP Synthesis-Adenosine triphosphate and sodium periodate 
were obtained from Sigma. o-ATP was synthesized according to  the 
procedure of Easterbrook-Smith  et al. (2). Reaction yields were mon- 
itored by thin layer chromatography on polyethyleneimine-cellulose 
plates (E. Merck, Darmstadt, W. Germany) developed with 0.8 M 
NH4HC03 using UV detection. The  o-ATP was purified by chroma- 
tography on a Sephadex G-10 column equilibrated with deionized 
water at 4 "C. Aliquots were stored at -70 "C and protected from 
light. 
Reaction of Hemoglobin with o-ATP-Hemoglobin A was isolated 
from freshly drawn human blood according to methods previously 
described (9).  The hemoglobin  was deoxygenated prior to reaction by 
flushing a solution in a round bottom flask on a  rotary  apparatus 
with nitrogen for 3 h at 0 "C. Hemoglobin concentration was 0.25 mM 
in 50 mM Tris, pH 7.8. Degassed o-ATP solution was introduced 
anaerobically to give a final concentration of 0.275 mM. Degassed 
sodium borohydride (10 mM) was added 30 min after  addition of o- 
ATP. The reaction was stopped by chromatography on a G-25 Seph- 
adex column equilibrated with 50 mM Tris,  pH 7.8. Modified hemo- 
globin  was purified by preparative ion-exchange chromatography on 
CM-Sephadex with a gradient consisting of 50 mM bis-Tris  run from 
pH 6.7 to 7.2 
HPLC of Hemoglobins and Peptides-Yields of modified  hemoglo- 
bin were determined by HPLC on  a cation exchange column (Polycat- 
A, Custom LC Inc., Houston, TX) (10) monitored a t  419 nm using 
an IBM System 9000 for peak integration.  Separation of globin chains 
was accomplished by reversed-phase HPLC on  a Vydac C, column 
(The Separations Group, Hesperia, CA), monitoring at  220 nm (11). 
Tryptic peptide separation was performed on a Vydac Cla large-pore 
reversed-phase column following a modification of the method of 
Shelton et al. (12) using a gradient between 0.1% trifluoroacetic acid 
(A) and 0.1% trifluoroacetic acid in acetonitrile (B).  The gradient ran 
from 0 to 13.6% B in 20 min, then  to 34% B in 50 min, then  to 100% 
B in  5 min, a t  a flow rate of 1 ml/min. 
Proteolytic Digestion-Trypsin (Worthington) was added to ace- 
tamidated,  heat-denatured Hb (1:50,  w/w) and incubated for 8 h at 
37 "C in 80 mM NH4C03, pH 8.5 Hb (native or modified) was 
acetamidated at p-93 Cys in order to solubilize tryptic peptide at-10 
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FIG. 1. Postulated structure of periodate-oxidized adeno- 
sine  triphosphate (Ref. 2). 
following a modification of the procedure of Goldstein et al. (13). 
Oxyhemoglobin (0.5 mM) was reacted with iodoacetamide (10 mM) 
for 2 h at 20 "C in 10 mM potassium phosphate, pH 7.0, and protected 
of Sephadex G-25. 
from light. The reaction was halted by chromatography on a column 
Gel Electrophoresis-Separation of cross-linked globin  from mon- 
omer was accomplished by electrophoresis in a 12% discontinuous 
polyacrylamide gel in the presence of sodium dodecyl sulfate and 
mercaptoethanol (14). 
Functional Testing-Oxygen equilibrium curves were determined 
at  a hemoglobin concentration of 15 pM in 50 mM bis-Tris buffer, pH 
7.4,O.l M C1-, at 20 "C, using an automated recording apparatus (15). 
A Cary 219 spectrophotometer and a polarographic oxygen electrode 
(Beckman Instruments 39065) were employed. Data aquisition and 
reduction were performed with a PDP 11/V03 computer (Digital 
Equipment Corp.) (16). 
X-ray Crystallography-Di-ATP Hb was crystallized in the deoxy 
form according to Perutz (17). Friedel pairs of about 14,000 reflections 
extending to 2.8-A resolution were collected from one crystal on a 
Hilger four-circle diffractometer. The data were corrected by the 
usual factors and scaled against the native data (21). The R-factor 
between Friedel pairs was 3.7% on intensity, that between derivative 
and native data was 6.5% on amplitude. An electron density difference 
map (&-ATP minus native deoxyhemoglobin) was calculated with 
phases from the native model (21). The map was contoured at rt0.06 
e/A3, or approximately rt3 times the root mean square density over 
the whole  cell (0.19 e/AS). 
RESULTS AND DISCUSSION 
Separation of o-ATP-modified  Derivatives-After reacting 
deoxyhemoglobin with o-ATP followed by reduction with 
sodium borohydride, the reaction mixture was chromato- 
graphed by cation-exchange HPLC (Fig. 2). The elution pro- 
file shows the appearance of one major reaction product 
eluting at 16.2 min. In addition, several minor peaks appear 
which elute in positions intermediate between HbA and  the 
major reaction product. These minor peaks include products 
containing intersubunit cross-linkages which exhibit in- 
creased oxygen affinity (6). The major peak eluting at 16.2 
min was preparatively purified by ion-exchange chromatog- 
raphy on CM-Sephadex with a  pH gradient of 50 mM bis- 
Tris,  pH 6.7-7.2. Sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis of this modified  hemoglobin revealed that  it 
contained no intersubunit cross-linkages (data not shown). 
Because o-ATP  has  a large extinction coefficient at 259 nm, 
it was  possible to obtain an estimate of the number of mole- 
cules of o-ATP associated with the modified  hemoglobin by 
spectroscopy (Table  I). The of  25.5 mM" corresponded 
to 1.7 molecules of o-ATP bound per tetramer, suggesting 
that  the product was disubstituted.  This product, designated 
di-ATP Hb, was produced consistently in a yield of 40-50% 
as determined by peak integration following cation-exchange 
HPLC. Although the molar ratio of o-ATP to hemoglobin 
tetramer was 1.1:l in the reaction mixture, the maximum 
yield of di-ATP Hb observed was 50%. Increasing the reagent 
to Hb  ratio  to 2.2:l did not result in  any  further increase in 
yield of di-ATP Hb. When the ratio of reagent to tetramer 
was further increased to lO:l,  there was a marked increase in 
the extent of modification; this was apparently due to heter- 
ogenous nonspecific reactions as evidenced by numerous new 
dl-AlP Hb 
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FIG. 2. Cation-exchange HPLC of crude reaction mixture 
following reaction of deoxyhemoglobin with o-ATP. Gradient 
and conditions are described under "Experimental Procedures." 
TABLE I 
Extinction coefficients at 259 nm (A,,- o-ATP) for native and o-ATP 
modified  hemoglobins 
Concentration of hemoglobins was determined for the cyanmet 
form on the basis of t510 = 44 mM" cm" (19). For o-ATP, €259 = 14.9 
mM" cm" (2). 
Native (CN-Met) 0.264 (6.00 pM) 0.618 103.0 0 
di-ATP (CN-Met) 0.269 (6.11 p M )  0.785 128.5 25.5 
peaks appearing during cation-exchange HPLC (data not 
shown). One possible mechanism to account for the observed 
50% limit in yield of di-ATP  Hb involves the dissociation and 
reassociation of hybrid species which can  take place following 
oxygenation during ion-exchange chromatography. In order 
for affinity labeling to take place, specific binding must occur 
followed  by covalent bond formation. It has been shown that 
only one molecule of the organic phosphate 2,3-diphospho- 
glycerate binds to the PIPz cleft of deoxyhemoglobin (18). 
Even more steric hindrance would  be expected in the case of 
o-ATP for a second molecule binding to  the cleft after  a  first 
molecule has bound. Thus,  an initial specific reaction of each 
deoxyhemoglobin tetramer with one molecule of o-ATP, fol- 
lowed  by subunit dissociation and reassociation upon oxygen- 
ation and ion-exchange chromatography would give rise to 
the following equilibrium. 
2 a2ppATP c-* 2 ap + 2 ,@ATP c-* ad32 + a28fTP 
Such a mechanism would lead to a yield of di-ATP  Hb with 
an upper limit of 50%. In order to confirm this mechanism, 
however, further  studies using anaerobic ion-exchange chro- 
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matography in order to  trap hybrid molecules in  the deoxy 
state will  be required. 
Tryptic Peptide Mapping-In order to determine the  sites 
of modification by o-ATP, ion-exchange purified HbA and  di- 
ATP Hb were iodoacetamidated, heat denatured, and sub- 
jected to trypsin digestion. After trypsin  treatment for 8 h at 
37 "C, the tryptic hydrolysates were chromatographed by  re- 
versed-phase HPLC. The a-globin tryptic peptides derived 
from di-ATP  Hb were identical to those of native a-globin. 
In  contrast, the tryptic map of @-globin tryptic peptides from 
di-ATP  Hb revealed the absence of the adjacent tryptic pep- 
tides Bt-9 and  fib10 (Fig. 3). In native @-globin, tryptic pep- 
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FIG. 3. CIS HPLC tryptic peptide maps of iodoacetamidated 
HbA (top) and di-ATP Hb (bottom). Arrows indicate positions of 
tryptic peptides Pt-9, @lo,  and  @t-lO,ll which are missing from the 
di-ATP Hb hydrolysate. 
FIG. 4. The difference map 
deoxy-di-ATP Hb minus HbA show- 
ing the region of the o-ATP-binding 
site. Solid contours, +0.06 e/A3; dashed 
contours, -0.06 e/A3. The atomic model 
is of native deoxy-HbA. There were no 
significant features  in the difference map 
outside of the region illustrated. 
tides  fit-9 and @t-10  are  split  as  a result of enzymatic hydrol- 
ysis at Lys-82 EF6, a residue found in the @& cleft which 
plays an important role in binding organic phosphates 
through ionic interactions (18). The absence of @t-9  and @t- 
10 suggests that reductive alkylation of the t-amino group of 
Lys-82 EF6 by o-ATP had occurred, inhibiting  tryptic cleav- 
age at this site and resulting in  the formation of a larger, 
presumably insoluble peptide. As would be expected, the 
tryptic fragment pt-10, 11, which in  native Hb hydrolysates 
is normally present in variable yield due to incomplete cleav- 
age, was also missing from the di-ATP  Hb hydrolysate. No 
other changes in the peptide pattern were observed. These 
results support the conclusion from spectroscopic studies 
indicating that  the protein  is  disubstituted,  as  both fi  chains 
have been modified and  the protein is not cross-linked. 
X-ray Crystallography-The electron density difference 
map of deoxy &-ATP Hb minus HbA obtained at 2.8-A 
resolution is shown in Figs. 4 and 5.  The most prominent 
features  in the map are  the symmetric positive double peaks 
in the central cavity between the two Lys-82 EF6 (Fig. 4). 
The 0-ATP molecules can be fitted  into  these peaks with the 
Lys-82 EF6 t-amino adduct as  either a bifunctional morpho- 
lino derivative (Fig. 5, a and b )  or as a monofunctional 
secondary amine involving a ?ingle aldehyde from C3'  of o- 
ATP (Fig. 5, c and d ) .  At 2.8-A resolution it is not possible to 
distinguish between these two possibilities, although the mor- 
pholino configuration appears to give a slightly better fit. In 
any case it is clear from the map that  the adenine rings take 
up a parallel "stacked configuration approximately 3.5 A 
apart. The map also shows a  prominent peak centered  near 
the site of Asn-139  H17. Since the atoms of this side chain 
have high temperature factors in the native structure, this 
peak probably represents  a reduction of the Asn mobility due 
to  its being trapped between the ligand and  the H helix. The 
negative peaks between the positive peaks discussed above 
probably result from the exclusion of water. Small negative 
peaks on the cavity side of helix H, near position H12, and 
even smaller positive ones away from the cavity near H10 and 
H15 suggest a slight opening of the cavity by o-ATP. Positive 
and negative peaks surrounding the side chain of His-143 
H21 indicate that this group moves toward the ATP and 
interacts  either with the phosphate or with the  3' hydroxyl 
in  the morpholino configuration. The exact position of the 
phosphate is not well determined in the map. It  may interact 
11012 
FIG. 5. Detailed view of o-ATP 
bound to Lys-82 EF6 either bifunc- 
tionally (a and b)  or  monofunction- 
ally at C3' only (c and d ) .  Parts a and 
c show the fit to  the difference map; solid 
contours: +0.06 e/A3; dashed contours: 
-0.06 e/A3; intermediate bonds: native 
model with the side chain of Asn-139 
HI7 shifted according to  the difference 
map; lightest bonds: symmetry-related o- 
ATP. Parts b and d show the binding in 
more detail, with bonded atoms labeled. 
The viewpoint is the same in all four 
parts of the figure. 
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FIG. 6. Oxygen equilibrium curves of HbA (squares) and di- 
ATP Hb (triangzes). Recordings  were  performed in 50 mM bis-Tris, 
pH 7.4, 0.1 M c1-, 20 "c. Hb concentration was 15 pM tetramer. 
also with His-2 NA2 or the  a-amino terminus of the (3 chain, 
but  the map shows no evidence of movement or localization 
of these groups. (The periodic progression of positive and 
negative peaks across the central cavity might suggest an 
artifact due to gross mis-measurement of a single reflection. 
In order to  test  this possibility, a difference map was calcu- 
lated  omitting  all 75 reflections with AF greater than  the root 
mean square of A F .  The difference maps calculated with and 
without these large AF values were virtually identical, ruling 
out  the possibility of such an artifact.) 
Functional Testing of o-ATP-modified Hb-Fig. 6 shows a 
comparison of the oxygen equilibrium curves for HbA and di- 
ATP Hb. Under the conditions tested (50 mM bis-Tris, pH 
7.4, 0.1 M C1-, 20 "C),  the Pm of di-ATP Hb is significantly 
increased relative to HbA (20.8 mm Hg versus  5.8  mm Hg). 
In addition, the subunit cooperativity of di-ATP Hb is reduced 
Conclusions-It has been demonstrated that o-ATP serves 
as  an efficient affinity label for the organic phosphate-binding 
site of deoxyhemoglobin  via adduct formation with p Lys-82 
EF6. It is noteworthy that while both affinity ligands o-ATP 
and pyridoxal phosphate label the organic phosphate-binding 
site, the amino acid residue involved in  o-ATP  adduct  for- 
mation is different from that of pyridoxal phosphate, which 
has been shown to involve an adduct with B Val-1 NA1 (20). 
Because of the lower pK  and hence greater nucleophilicity of 
the @-amino termini compared with the €-amino group of Lys- 
82 EF6, they  are more susceptible to alkylation by carbonyl 
attacking groups. The modification of p Lys-82 EF6 by o- 
ATP  and lack of evidence of any reaction products involving 
the amino  termini imply a stereochemical binding conforma- 
tion  in  the  central cavity which would  specifically favor re- 
action with the €-amino group, 
It has been previously demonstrated that  the formation of 
= 1.9; control nmax = 2.7). 
mukiple cross-linked, singly-modified, high-affinity reaction 
products from the reaction of 0-ATP with deoxyhemoglobin 
can be favored by the use of the milder reducing agent 
cyanoborohydride in place of borohydride (6). In contrast, 
reduction with borohydride leads to selective formation of the 
product described in  this work, &-ATP Hb, which exhibits  a 
significantly lowered  oxygen affinity and  subunit cooperativ- 
ity. The structure of the molecule determined by x-ray crys- 
tallography suggests a possible mechanism for these func- 
tional changes. Both molecules of o-ATP  are  protruding  into 
the BIB2 cleft with the planes of the adenine rings 3.5 A apart 
and parallel to each other. The subunit motion in the  EF 
regions of the  central cavity induced by oxygenation would 
tend  to push the adenine  rings closer together, resulting in 
steric repulsion inhibiting the T to R conformational transi- 
tion. The expected functional effect of this would be a reduc- 
tion in oxygen affinity due to the shift of the allosteric 
equilibrium towards a  T-like  state. Such a mechanism would 
also be consistent with the observed reduction in subunit 
cooperativity in  di-ATP Hb. 
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